tiprankstipranks
Herbalife Ltd (HLF)
NYSE:HLF
US Market
Want to see HLF full AI Analyst Report?

Herbalife (HLF) Earnings Dates, Call Summary & Reports

543 Followers

Earnings Data

Report Date
Aug 04, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.63
Last Year’s EPS
0.59
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 06, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized clear operational and financial progress—including net sales and adjusted EBITDA beating guidance, strong India performance, meaningful refinancing savings (~$45M annualized), improved cash generation ($114M operating cash flow), and strategic M&A and digital initiatives to accelerate personalized nutrition. Offsetting these positives were region-specific challenges: softness in EMEA and North America (weather and timing), a notable decline in China (volume -18%), modest gross margin pressure from mix and input cost dynamics, and an expected $20–25M FY EBITDA headwind from India GST mismatches. On balance, the company presented multiple durable positives that outweighed the localized and timing-related headwinds, while setting conservative guidance assumptions for FX and tax impacts.
Company Guidance
Herbalife reiterated a disciplined outlook anchored by a strong Q1 (net sales $1.3B, +7.8% YoY / +5.4% cc; adjusted EBITDA $176M; cash from operations $114M; adjusted diluted EPS $0.64), and guided Q2 net sales to +1.5%–5.5% reported (+1%–5% cc) with adjusted EBITDA $150M–$170M, and full‑year 2026 net sales to +1.5%–5.5% reported (+1%–5% cc) and adjusted EBITDA $675M–$705M; management noted a reduced FX tailwind (now ~50 bps vs. prior 100 bps) and specific headwinds including an ~ $10M QoQ EBITDA impact in Q2 ($5M China grant timing, $5M India GST mismatch) and an expected India GST-related drag of ~$20M–$25M (≈40–50 bps) on full‑year adjusted EBITDA. They reaffirmed capex of $50M–$80M (Q2 $15M–$25M), capitalized SaaS $35M–$55M, an anticipated adjusted effective tax rate of ~30%, and balance‑sheet targets following a $1.45B refinancing (including $800M 7.75% notes) that should yield ~ $45M of annual cash interest savings; leverage stood at 2.7x total (net leverage 2.1x) with a target to get net leverage below 2.0x by year‑end and reduce gross debt to ~ $1.4B by 2028.
Revenue Growth Above Guidance
First quarter net sales of $1.3 billion, up 7.8% year-over-year and up 5.4% on a constant currency basis, exceeding guidance and marking the third consecutive quarter of year-over-year net sales growth.
Adjusted EBITDA Outperformance
Adjusted EBITDA of $176 million, above the high end of guidance ($155M–$175M); adjusted EBITDA margin 13.3% (down 20 basis points YoY, up 240 basis points versus a two-year stack).
Strong India Performance
India delivered record quarterly net sales of ~$275 million, up approximately 32% year-over-year (local currency +39%), driven by ~37% volume growth and sustained momentum after the GST reduction.
Solid Cash Generation
Operating cash flow of $114 million in the quarter (typical seasonally low quarter), compared to relatively neutral cash flow in the prior year; cash balance ended the quarter at $451 million, up nearly $100 million YoY.
Successful Debt Refinancing and Deleveraging
Completed $1.45 billion senior secured refinancing in April, reducing coupons and spreads (senior secured notes coupon reduced by 450 bps), extending maturities to >7 years, and expected to yield approximately $45 million in annual cash interest savings; total leverage ratio reduced from 3.9x in 2023 to 2.7x at quarter end and net leverage 2.1x with a target to reduce net leverage below 2x by year-end.
Strategic Acquisitions to Accelerate Personalization
Completed four acquisitions (Vionic asset purchase: $55M base consideration, up to $95M contingent; Link Biosciences; Prüvit; Protocol) to enable personally formulated products and digital personalization; Vionic rollout to 11 EMEA countries in June and U.S. in July.
Volume and Pricing Contributions
Worldwide volume increased 4.1% year-over-year; pricing provided an approximately $40 million benefit to net sales in the quarter, while FX provided a ~$29 million benefit (approx. 240 basis points tailwind).
Operational and Margin Progress vs. 2024
Expanded Q1 adjusted EBITDA margins by ~240 basis points since 2024 and repaid nearly $540 million of debt since 2024, demonstrating improved operational efficiency and balance sheet strength.

Herbalife (HLF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

HLF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 04, 2026
2026 (Q2)
0.63 / -
0.59
May 06, 2026
2026 (Q1)
0.61 / 0.64
0.598.47% (+0.05)
Feb 18, 2026
2025 (Q4)
0.48 / 0.45
0.3625.00% (+0.09)
Nov 05, 2025
2025 (Q3)
0.46 / 0.50
0.57-12.28% (-0.07)
Aug 06, 2025
2025 (Q2)
0.50 / 0.59
0.549.26% (+0.05)
Apr 30, 2025
2025 (Q1)
0.41 / 0.59
0.4920.41% (+0.10)
Feb 19, 2025
2024 (Q4)
0.19 / 0.36
0.2828.57% (+0.08)
Oct 30, 2024
2024 (Q3)
0.31 / 0.57
0.65-12.31% (-0.08)
Jul 31, 2024
2024 (Q2)
0.41 / 0.54
0.74-27.03% (-0.20)
May 01, 2024
2024 (Q1)
0.38 / 0.49
0.54-9.26% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

HLF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2026
$16.44$14.49-11.86%
Feb 18, 2026
$16.54$19.57+18.32%
Nov 05, 2025
$8.24$9.20+11.65%
Aug 06, 2025
$9.25$8.62-6.81%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Herbalife Ltd (HLF) report earnings?
Herbalife Ltd (HLF) is schdueled to report earning on Aug 04, 2026, After Close (Confirmed).
    What is Herbalife Ltd (HLF) earnings time?
    Herbalife Ltd (HLF) earnings time is at Aug 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is HLF EPS forecast?
          HLF EPS forecast for the fiscal quarter 2026 (Q2) is 0.63.